Fujifilm’s Aspire Cristalle breast imaging system violates four patents owned by Hologic, according to the initial ruling on July 26 of U.S. International Trade Commission Judge Clark Cheney.
The investigation is scheduled to be complete by Nov. 26, according to a report from Bloomberg Law. These findings are still subject to review, and the judge’s full opinion will be made public once both vendors have redacted confidential business information.
The dispute began in June 2017 when Hologic filed suit again Fujifilm Holdings over violation of the patents. The two vendors met with a mediator in February, but they were unable to resolve the conflict. Fujifilm filed a lawsuit against Hologic in March alleging Hologic’s Selenia Dimensions mammography systems infringe their own patents.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.